Alignment Healthcare announces a public offering of 13.2 million shares by General Atlantic, with no proceeds to the company.
Quiver AI Summary
Alignment Healthcare, Inc. has announced the start of an underwritten public offering of 13,167,733 shares of its common stock, being sold by an affiliate of General Atlantic, L.P. The company will not receive any proceeds from this sale, and J.P. Morgan is acting as the underwriter. The offering is conducted under a shelf registration statement filed with the SEC that became effective on March 2, 2026. Interested parties can access related documents for free via the SEC website or by contacting J.P. Morgan directly. Alignment Healthcare emphasizes its mission to provide high-quality, affordable care for Medicare Advantage members and is focused on expanding its national presence while prioritizing senior care. The press release includes forward-looking statements and outlines various risks that could impact future performance.
Potential Positives
- The initiation of an underwritten public offering indicates investor confidence in Alignment Healthcare, as it involves the sale of a significant number of shares.
- Alignment Healthcare's status as an award-winning Medicare Advantage company strengthens its reputation and market presence.
- The company's mission-focused approach and commitment to high-quality, low-cost care for Medicare Advantage members position it favorably in the competitive healthcare market.
- The effective filing of a shelf registration statement enables the company to streamline future capital raises, fostering operational flexibility and growth opportunities.
Potential Negatives
- The company is not receiving any proceeds from the public offering, which could raise concerns about capital raising efforts and financial stability.
- The involvement of a selling stockholder may signal potential lack of confidence from insiders or investors regarding the company's future performance.
- The press release highlights various risks and uncertainties associated with the company, which could indicate operational challenges and instability in future growth and performance.
FAQ
What is the recent public offering announced by Alignment Healthcare?
Alignment Healthcare announced a public offering of 13,167,733 shares by an affiliate of General Atlantic, L.P.
Who is the underwriter for this stock offering?
J.P. Morgan is acting as the underwriter for the proposed stock offering.
Will Alignment Healthcare receive proceeds from the stock sale?
No, Alignment Healthcare will not receive any proceeds from the sale of the shares.
Where can I find the prospectus for this stock offering?
The prospectus can be obtained for free on the SEC website at www.sec.gov or by contacting J.P. Morgan.
What does Alignment Healthcare focus on?
Alignment Healthcare focuses on empowering seniors through high-quality, low-cost Medicare Advantage care and coordinated services.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ALHC Insider Trading Activity
$ALHC insiders have traded $ALHC stock on the open market 51 times in the past 6 months. Of those trades, 0 have been purchases and 51 have been sales.
Here’s a breakdown of recent trading of $ALHC stock by insiders over the last 6 months:
- ATLANTIC, L.P. GENERAL has made 0 purchases and 3 sales selling 30,825,590 shares for an estimated $521,983,600.
- ATLANTIC (ALN HLTH), L.P. GENERAL has made 0 purchases and 3 sales selling 30,825,590 shares for an estimated $521,983,600.
- JOHN E KAO (Chief Executive Officer) has made 0 purchases and 11 sales selling 2,040,666 shares for an estimated $37,089,474.
- DAWN CHRISTINE MARONEY (President) has made 0 purchases and 12 sales selling 1,015,884 shares for an estimated $19,591,782.
- HYONG KIM (Chief Medical Officer) has made 0 purchases and 5 sales selling 114,234 shares for an estimated $2,074,967.
- ROBERT L. SCAVO (Chief Information Officer) has made 0 purchases and 4 sales selling 99,076 shares for an estimated $1,787,984.
- JOSEPH S KONOWIECKI has made 0 purchases and 5 sales selling 95,908 shares for an estimated $1,690,753.
- CHRISTOPHER J JOYCE (Chief Legal and Admin. Officer) has made 0 purchases and 6 sales selling 77,443 shares for an estimated $1,404,519.
- ANDREAS P. WAGNER (Chief Human Resources Officer) sold 22,238 shares for an estimated $455,211
- SEBASTIAN BURZACCHI (COO - Mgmt Services Org) sold 12,585 shares for an estimated $242,387
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ALHC Revenue
$ALHC had revenues of $1B in Q4 2025. This is an increase of 44.43% from the same period in the prior year.
You can track ALHC financials on Quiver Quantitative's ALHC stock page.
$ALHC Hedge Fund Activity
We have seen 173 institutional investors add shares of $ALHC stock to their portfolio, and 116 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GENERAL ATLANTIC, L.P. removed 11,119,494 shares (-45.8%) from their portfolio in Q4 2025, for an estimated $219,610,006
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 10,874,567 shares (-86.5%) from their portfolio in Q4 2025, for an estimated $214,772,698
- FMR LLC added 6,574,721 shares (+81.4%) to their portfolio in Q4 2025, for an estimated $129,850,739
- WELLINGTON MANAGEMENT GROUP LLP added 2,981,166 shares (+26.9%) to their portfolio in Q4 2025, for an estimated $58,878,028
- MILLENNIUM MANAGEMENT LLC removed 2,924,624 shares (-53.3%) from their portfolio in Q4 2025, for an estimated $57,761,324
- CAPITAL WORLD INVESTORS added 2,238,147 shares (+inf%) to their portfolio in Q4 2025, for an estimated $44,203,403
- LOOMIS SAYLES & CO L P added 2,236,058 shares (+inf%) to their portfolio in Q4 2025, for an estimated $44,162,145
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ALHC Analyst Ratings
Wall Street analysts have issued reports on $ALHC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 01/06/2026
- JP Morgan issued a "Overweight" rating on 11/24/2025
- Goldman Sachs issued a "Buy" rating on 10/14/2025
To track analyst ratings and price targets for $ALHC, check out Quiver Quantitative's $ALHC forecast page.
$ALHC Price Targets
Multiple analysts have issued price targets for $ALHC recently. We have seen 7 analysts offer price targets for $ALHC in the last 6 months, with a median target of $23.0.
Here are some recent targets:
- John Stansel from JP Morgan set a target price of $26.0 on 02/05/2026
- Ryan Langston from TD Cowen set a target price of $25.0 on 01/16/2026
- Kevin Caliendo from UBS set a target price of $21.0 on 01/14/2026
- Jessica Tassan from Piper Sandler set a target price of $30.0 on 01/06/2026
- Andrew Mok from Barclays set a target price of $18.0 on 11/03/2025
- Scott Fidel from Goldman Sachs set a target price of $21.0 on 10/14/2025
Full Release
ORANGE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) (“Alignment Healthcare” or the “Company”), an award-winning Medicare Advantage (MA) company, today announced the commencement of an underwritten public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L.P. (the “Selling Stockholder”). The Company will not receive any of the proceeds from the sale of the shares of its common stock being offered by the Selling Stockholder.
J.P. Morgan is acting as the underwriter for the proposed offering.
The offering is being made pursuant to a shelf registration statement on Form S-3, which has been filed by the Company with the Securities and Exchange Commission (the "SEC") and became effective upon filing on March 2, 2026. The offering will be made only by means of a prospectus supplement and an accompanying prospectus. You may obtain these documents for free by visiting EDGAR on the SEC website at www.sec.gov , or by contacting: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at [email protected] and [email protected] .
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Alignment Healthcare
Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health’s mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day. Based in California, the company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include, among others, statements concerning the expected closing of the offering. Forward-looking statements are subject to risks and uncertainties and are based on assumptions that may prove to be inaccurate, which could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to attract new members and enter new markets, including the need for certain governmental approvals; our ability to maintain a high rating for our health plans on the Five Star Quality Rating System; our ability to develop and maintain satisfactory relationships with care providers that service our members; risks associated with being a government contractor; changes in laws and regulations applicable to our business model; risks related to our indebtedness; changes in market or industry conditions and receptivity to our technology and services; results of litigation or a security incident; and the impact of shortages of qualified personnel and related increases in our labor costs. There can be no assurance that Alignment Healthcare will be able to complete the offering on the anticipated terms, or at all. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our Annual Report on Form 10-K for the year ended December 31, 2025, and the other periodic reports we file with the SEC. All information provided in this release is as of the date hereof, and we undertake no duty to update or revise this information unless required by law.
Investor Contact Harrison Zhuo [email protected]
Media
Contact
Priya Shah
mPR, Inc. for Alignment Healthcare
[email protected]